Preventing the next global health crisis

Our mission is to prevent and alleviate the global health crisis caused by the pathogenic bacteria resistant to antibiotics

Vaccines against antibiotic-resistant infections

Bacterial infections can be prevented by boosting and refocusing the body’s natural immunity. Vaxdyn develops safe and effective vaccines against the most worrisome bacterial pathogens.

THE COMPANY

We work with an international network of collaborators on the development of multi-valent vaccines for preventing antibiotic-resistant infections in all regions of the world.

OUR TECHNOLOGY

Vaxdyn’s proprietary technology marks a step change in bacterial vaccinology: an LPS-null whole-cell platform that focuses immunity on conserved outer membrane proteins rather than serotype-specific capsules.

PIPELINE

Vaxdyn created a new proprietary technology by transforming AcinetoVax, a monovalent vaccine candidate, into a technological platform able to deliver multi-valent vaccines for raising immunity against the most worrisome anti-microbial resistant bacteria.

View more
Vaxdin-bacteria hero home

OUR LATEST NEWS

STAY INFORMED OF ALL OUR LATEST NEWS

You will find all the news about Vaxdyn and our initiatives.

CONTACT

Vaxdyn

Supported by

CONTACT US


Vaxdyn logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.